Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by Hempdocon Aug 04, 2020 5:19am

197 Views

Post# 31359580

RE:RE:RE:Secret

Perhaps our bigger silver lining....I'm feeling more confident by the day that Lumeda Inc. & Roswell can help shine an even brighter light on TLD1433 by optimizing the OSA for intraoperative use in peripheral NSCLC/pleural mets/mesothelioma. Thankfully, Dr. Sherri has called in the reinforcements ; )

Bullboard Posts

HPQ Silicon updates shareholders on Fumed Silica Reactor developments